Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|October 1, 1988
The effect of transportation between the recovery room and intensive care unit on postoperative acoustic tumor patientsC W Hamm, J H Robertson, J T Robertson, et al.
Deutsche Medizinische Wochenschrift (1946)|February 11, 1994
[One session diagnostic heart catheterization and balloon dilatation ("prima vista"-PTCA): results and risks]G K Lund, C A Nienaber, C W Hamm, et al.
Circulation|February 15, 1995
Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a)W Terres, E Tatsis, B Pfalzer, et al.
The American Journal of Otology|October 1, 1983
Acoustic tumor management--combined approach surgery with CO2 laserG Gardner, J H Robertson, W C Clark, et al.
The New England Journal of Medicine|October 20, 1994
A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI)C W Hamm, J Reimers, T Ischinger, et al.
The New England Journal of Medicine|December 4, 1997
Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin IC W Hamm, B U Goldmann, C Heeschen, et al.
The Thoracic and Cardiovascular Surgeon|July 17, 2007
Left ventricular tamponade - a clinical chameleonH Möllmann, A Zirlik, H M Nef, et al.
Lancet (London, England)|November 30, 1999
Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome ManagementC Heeschen, C W Hamm, B Goldmann, et al.
American Heart Journal|October 1, 1995
Endogenous tissue plasminogen activator and platelet reactivity as risk factors for reocclusion after recanalization of chronic total coronary occlusionsW Terres, G K Lund, A Hübner, et al.
European Heart Journal|August 1, 1983
Haemodynamic and cardiac metabolic effects of the new beta 1 agonist prenalterol in patients with cardiac failureW Kupper, M Schütt, C W Hamm, et al.
Pageof 15